JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258517

Human MKNK2 (MNK2) knockout HEK-293T cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

MKNK2 KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 20 bp deletion in exon2 and 4 bp deletion in exon2.
2 Images
Sanger Sequencing - Human MKNK2 (MNK2) knockout HEK-293T cell lysate (AB258517)
  • Sanger seq

Unknown

Sanger Sequencing - Human MKNK2 (MNK2) knockout HEK-293T cell lysate (AB258517)

Allele-2 : 4 bp deletion in exon2

Sanger Sequencing - Human MKNK2 (MNK2) knockout HEK-293T cell lysate (AB258517)
  • Sanger seq

Unknown

Sanger Sequencing - Human MKNK2 (MNK2) knockout HEK-293T cell lysate (AB258517)

Allele-1 : 20 bp deletion in exon2

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 20 bp deletion in exon2 and 4 bp deletion in exon2.

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258517-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human MKNK2 knockout HEK293T cell lysate", "number":"AB258517-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HEK293T cell lysate", "number":"AB258517-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
MKNK2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The MNK2 kinase also known as MAP kinase-interacting serine/threonine-protein kinase 2 is a protein that plays a critical role in regulating mRNA translation. It weighs approximately 51 kDa and is part of the larger mitogen-activated protein kinase (MAPK) family. This protein is expressed widely across various tissues including the brain and liver. Its primary function is to phosphorylate specific substrates involved in the process of gene expression control.
Biological function summary

MNK2 modulates stress responses by influencing protein synthesis. It is an integral component of the mRNA translation machinery. MNK2 phosphorylates the eukaryotic translation initiation factor 4E (eIF4E) a process that is fundamental for the translation of specific mRNAs. By regulating eIF4E activity MNK2 helps to control the translation of mRNAs involved in stress response and cellular growth.

Pathways

MNK2 is significantly involved in the MAPK signaling pathway and plays a role in the response to cellular stress and growth signals. This pathway includes MAP kinases like ERK which activate MNK2. Through its interaction with eIF4E MNK2 facilitates the synthesis of proteins that are important for cell survival and proliferation in response to extracellular signals. Its action links upstream signaling events influenced by MAP kinases to downstream processes affecting cell growth and stress response.

MNK2 has been implicated in cancer due to its role in the regulation of protein synthesis that supports cell proliferation. Abnormal MNK2 activity is linked to tumorigenesis particularly in cancers where eIF4E plays a role like breast and prostate cancer. Moreover its interaction with proteins such as eIF4E and MAP kinases highlights potential targets for therapeutic intervention. By modulating MNK2 activity researchers aim to control aberrant protein synthesis pathways driving these diseases.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com